This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
| less than a minute read

Time to pay attention to Psychedelic Medicine says The Motley Fool

As previously highlighted in other posts, investors should keep an eye out for stocks in the psychedelic medicine space. Mind Medecine, Compass Pathways and Field Trip Ventures are all candidates to go public in the next 12 months. 

Are we with psychedelic medicine where we were with cannabis 10-15 years ago?

What's important to understand is that a paradigm shift is starting to taking shape within the Western medical community. In effect, scientists are increasingly intrigued by the therapeutic potential of psychedelics as treatments for a whole range of mental health disorders. Pyschedelic medicine thus has the potential to be a gold mine for early investors.

Tweets on this subject